TAS-115 is expected to exert a similar inhibitory effect and may also suppress the differentiation of M2-like macrophages, involved in cancer-related inflammation, tumour growth, and progression [26], via colony-stimulating factor-1 receptor (CSF-1R) inhibition [27], as well as improve antitumour immune defences in the tumour microenvironment. This evidence concerns the gene CSF1R and neoplasm.